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Abstract
Introduction:  Intrathecal  ﬂuorescein  has  been  effective  for  topographic  diagnosis  of  rhinoliqu-
orrhea. Nonetheless,  there  are  no  reports  on  the  study  of  cerebral  spinal  ﬂuid  (CSF)  after  use
of intrathecal  ﬂuorescein.
Objective:  A  prospective  study  attempting  to  evaluate  CSF  through  chemical  and  cytological
analysis, after  injection  of  ﬂuorescein.
Methods:  Prospective  analysis  of  24  samples  of  CSF  after  intrathecal  injection  of  ﬂuorescein
for topographic  diagnosis  of  CSF  ﬁstulae,  collected  at  the  time  of  puncture  and  after  24  and
48 h,  divided  by  cellularity:  Group  1,  up  to  ﬁve  cells,  and  Group  2,  with  more  than  ﬁve  cells.
Results: The  yellow-greenish  color  of  CSF  remained  after  48  h  in  36%,  evidencing  permanence
of ﬂuorescein.  No  changes  in  protein  and  glucose  levels  were  observed  between  0--24  h  and
0--48 h.  In  group  2,  an  increase  in  cell  count  was  observed  between  24  h  and  48  h  (p  =  0.019).  In
both groups,  there  was  an  increase  of  neutrophils  between  0  and  48  h  (p  =  0.048)  and  a  decrease
between 24  and  48  h  (p  =  0.05).
 Please cite this article as: Guimarães RES, Stamm AEC, Giannetti AV, Crosara PFTB, Becker CG, Becker HMG. Chemical and cytological
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Conclusion:  Intrathecal  ﬂuorescein  provoked  discreet  meningeal  reactions,  such  as  an  increase
of cells  between  24  and  48  h  and  an  increase  of  neutrophils  at  24  h,  with  a  subsequent  decrease
at 48  h  with  no  correlation  with  symptomatology.
© 2015  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Published  by
Elsevier Editora  Ltda.  All  rights  reserved.
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Análise  química  e  citológica  do  líquor  após  injec¸ão intratecal  de  soluc¸ão hipodensa
de  ﬂuoresceína
Resumo
Introduc¸ão: A  ﬂuoresceína  intratecal  tem  sido  efetiva  no  diagnóstico  topográﬁco  da  rinoliquor-
réia. Entretanto,  não  há  estudos  no  líquor  após  o  uso  de  ﬂuoresceína  intratecal.
Objetivo:  Estudo  prospectivo  visando  avaliar  o  líquor,  através  de  análise  química  e  citológica,
após injec¸ão  de  ﬂuoresceína.
Método:  Análise  prospectiva  de  24  punc¸ões  após  injec¸ão  intratecal  de  ﬂuoresceína  para  diag-
nóstico topográﬁco  de  fístula  liquórica,  coletado  no  momento  da  punc¸ão,  24  e  48  horas,  divididos
pela celularidade:  grupo  1,  com  até  5  células  e  grupo  2  com  mais  de  5  células.
Resultado:  A  colorac¸ão  amarelo-esverdeada  do  líquor  permaneceu  após  48  horas  em  36%,
evidenciando  permanência  de  ﬂuoresceína.  Observou-se  ausência  de  mudanc¸as  no  nível  de
proteína e  glicose  entre  0--24  horas  e  0--48  horas.  No  grupo  2,  um  aumento  na  contagem  celular
foi observado  entre  24  e  48  horas  (p  =  0,019).  No  dois  grupos  juntos,  observou-se  um  aumento
de neutróﬁlos  entre  0  e  48  horas  (p  =  0,048)  e  uma  diminuic¸ão  entre  24  e  28  horas  (p  =  0,05).
Conclusão:  Fluoresceína  intratecal  provocou  discretas  reac¸ões  meníngeas,  como  o  aumento
de células  entre  24  e  48  horas  e  aumento  dos  neutróﬁlos  em  24  horas  com  uma  subsequente
diminuic¸ão em  48  horas  sem  correlac¸ão  com  sintomas.
© 2015  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Publicado  por
Elsevier Editora  Ltda.  Todos  os  direitos  reservados.
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general  anesthesia  at  the  beginning  of  surgery.  CSF  was  col-ntroduction
erebral  spinal  ﬂuid  (CSF)  ﬁstulae  can  occur  from  nose  or
xternal  ear  canal,  and  from  a  traumatic  or  surgical  defect
n  skull  base  or  spine.  Fluid  leakage  is  the  result  of  dural
nd  arachnoid  laceration,  with  ﬁstula  formation.  CSF  rhin-
rrhea  is  classically  deﬁned  as  the  presence  of  CSF  in  nasal
avity,  which  implies  the  existence  of  a  bone  and  dural
efect  resulting  in  a  communication  between  the  subarach-
oid  space  and  the  upper  airway  cavities.1 These  situations
equire  a  precise  diagnosis  for  their  etiology  and  location,2,3
ogether  with  a  suitable  treatment,  due  to  an  increased  risk
f  neurological  complications,  mainly  bacterial  meningitis.
Although  there  have  been  several  advances  in  preopera-
ive  tests  and  in  examinations  to  diagnose  CSF  rhinorrhea,
he  use  of  ﬂuorescein,  which  began  in  the  1960s,  has  been
roven  effective  as  to  detection  of  sites  of  CSF  ﬁstulae.4--9
However,  reports  of  adverse  reactions  are  few,  and  are
ainly  related  to  high  concentrations  of  ﬂuorescein;  some
enters  are  still  hesitant  to  use  this  strategy  routinely.10--18 In
001,  a  ﬂuorescein  solution  was  described  in  order  to  facil-
tate  and  hasten  the  identiﬁcation  of  ﬁstula  sites.  Previous
tudies  describing  the  use  and  safety  of  an  intrathecal  hypo-
ense  ﬂuorescein  solution  have  already  been  published,  but
hey  rarely  evaluate  the  changes  in  CSF  due  to  its  use.
The  objective  of  this  study  was  to  determine  the  changes
n  CSF  after  using  a  hypodense  ﬂuorescein  solution.  Changes
l
tn  coloration,  cellularity,  and  glucose  and  protein  levels  in
SF  of  patients  submitted  to  its  use  were  evaluated.
ethods
his  was  a  prospective  study  of  24  consecutive  patients  aged
--54  years  (mean,  31  years)  submitted  to  an  intrathecal
njection  of  hypodense  ﬂuorescein  solution  for  an  endo-
copic  intraoperative  diagnosis  of  CSF  leakage  from  the
nterior  aspect  of  skull  base.
All  patients  provided  informed  consent  after  a  discus-
ion  of  the  risks,  beneﬁts,  and  alternatives.  The  study  was
pproved  by  the  Ethics  Committee  of  the  institution  under
o.  ETIC  075/00.
Thirteen  patients  were  male  (54%)  and  11  female  (46%).
he  main  cause  of  CSF  rhinorrhea  was  a  traumatic  event  in
4  patients  (58%),  spontaneous  rhinorrhea  in  ﬁve  patients
21%),  and  meningocele  or  meningoencephalocele  in  ﬁve
atients  (21%).  The  exclusion  criterion  was  the  occurrence
f  meningitis  in  a  previous  period  of  three  months.  No
atients  were  excluded  from  this  study.
All  patients  were  submitted  to  a  lumbar  puncture  underected  at  this  time  for  chemical  and  cytological  analysis.
After  CSF  collection,  if  the  patient  weighed  more
han  50  kg,  0.5  mL  of  5%  ﬂuorescein  solution  diluted  with
jection  of  hypodense  ﬂuorescein  551
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Figure  1  Cellularity  in  both  groups  (1  and  2)  related  to  time:
0 h,  24  h,  and  48  h.
10,0
8,0
6.0
In
cr
ea
se
 (p
erc
en
tag
e)
Increase 24h
Increase 48h
4,0
2,0
0,0
–2,0
14
≤5 ≥6
14
Initial number of cells
10 10
Circles indicate outlier.
F
t
o
o
o
e
iChemical  and  cytological  analysis  of  CSF  after  intrathecal  in
10  mL  of  distilled  water  was  injected.  If  the  patient
weighted  less  than  50  kg,  or  in  children,  0.1  mL/kg  of  the
described  solution  was  injected.19 This  study  used  Fluidag®
(sodium  ﬂuorescein,  sodium  bicarbonate,  and  phenylmer-
curic  nitrate;  Oftalmopharma  --  São  Paulo,  Brazil).  Fludiag®
consists  of  a  solution  of  5%  sodium  ﬂuorescein  dissolved  in  a
physiologically  compatible  buffer  containing  sodium  bicar-
bonate  as  alkalinizing  agent  in  order  to  maintain  the  pH  in
an  8.0--9.8  range,  0.0001%  phenylmercuric  nitrate  as  preser-
vative,  and  water  for  injection.
Soon  after  the  injection,  which  was  slowly  performed
over  2--3  min,  the  patient  was  positioned  supine,  with
his/her  back  slightly  raised  at  approximately  30◦;  then,  the
surgery  was  initiated.
After  surgery  and  with  the  CSF  ﬁstula  endoscopically
closed,  a  lumbar  drainage  catheter  inserted  for  the  injection
of  ﬂuorescein  was  kept  closed.  CSF  samples  were  collected
at  24  h  and  48  h  after  the  procedure.  These  samples  were
submitted  to  chemical/cytological  analysis.
Chemical  analysis  of  CSF  included  color  (green,  yellow-
green,  or  clear),  and  glucose  and  protein  levels  by  a
colorimetric  method.
In  the  cytological  analysis,  total  number  of  erythrocytes
and  nucleated  cells  (neutrophils,  lymphocytes,  monocytes,
eosinophils,  and  basophils)  was  obtained.  A  Neubauer  cham-
ber  was  used  for  cytological  analysis.
The  patients  were  divided  into  two  groups,  according  to
their  initial  number  of  cells  in  CSF:  Group  1 (up  to  ﬁve  cells
per  mL)  and  Group  2  (more  than  ﬁve  cells  per  mL).  These
groups  were  compared,  with  the  aim  to  examine  the  differ-
ence  between  glucose  and  protein  levels  and  cellularity.
The  study  design  made  no  provision  for  a  control  group,
that  is,  one  without  ﬂuorescein  injection.
All  results  were  statistically  analyzed  using  Pearson’s
coefﬁcient,  with  statistical  signiﬁcance  set  at  95%  (p  <  0.05).
Results
In  all  cases,  hypodense  ﬂuorescein  present  in  the  endo-
scopic  surgical  ﬁeld  was  detected,  with  successful  closure
of  CSF  ﬁstula.  There  was  no  need  to  use  special  light  ﬁl-
ters.  There  were  no  complications,  adverse  reactions,  or
meningitis  cases  in  the  whole  sample  of  24  patients.  Group
1  included  14  patients  and  Group  2,  ten  patients.
As  to  CSF  staining,  CSF  samples  collected  before  ﬂuo-
rescein  injection  were  clear  in  all  patients.  At  24  h,  in
20  patients  (80%)  a  predominantly  yellow-green  color  was
observed,  indicating  presence  of  ﬂuorescein.  At  48  h,  nine
patients  (36%)  still  exhibited  a  yellow-green  color  in  their
CSF  samples.
As  to  glucose  level,  there  was  no  statistically  signiﬁcant
difference  between  the  two  groups  accessed  concomitantly
at  the  zero-h  (p  =  0.5),  24-h  (p  =  0.24),  or  48-h  (p  =  0.5)  mea-
surements.
Regarding  protein  level,  there  was  no  statistically  signif-
icant  difference  with  respect  to  protein  levels  between  the
two  groups  analyzed  concomitantly  at  zero-h  (p  =  0.37)  and
24-h  (p  =  0.16)  measurements.  At  the  48-h  measurement,  a
statistically  signiﬁcant  difference  was  observed,  with  eleva-
tion  of  protein  levels  in  Group  1  (p  =  0.032).
4
v
(igure  2  Percentage  of  cells  in  both  groups  (1  and  2)  related
o time:  0  h,  24  h  and  48  h.
As  to  cell  count,  an  increase  in  this  parameter  was  also
bserved.  In  Group  1,  almost  all  patients  showed  an  increase
f  600%,  when  compared  to  cell  count  baseline  values.  Half
f  the  patients  showed  an  increase  in  their  cell  counts  in
xcess  of  100%  in  both  groups  (Figs.  1  and  2,  Table  1).
Among  Group  2 patients,  a statistically  signiﬁcant
ncrease  in  cell  count  was  observed  at  48  h.
The  percentage  of  neutrophils  was  similar  for  24-h  and
8-h  measurements  in  both  groups;  compared  to  baseline
alues,  an  increase  at  24  h  (p  =  0.048)  and  a  decrease  at  48  h
p  =  0.05)  were  noted  (Fig.  3,  Table  2).
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Table  1  Number  of  cells  according  to  time  course  and  initial  cell  number.
Initial  cell  number  Time  elapsed  after  ﬂuorescein  infusion  p-value
0  h 24  h  48  h  0  h  vs.  24  h  0  h  vs.  48  h  24  h  vs.  48  h
Mean  SD  Mean  SD  Mean  SD
≤5 2.3 1.6  6.6  8.8  4.5  5.1  0.078  0.112  0.183
≥6 26.2 22.5 26.2 29.5 38.8 38.7  1.0000  0.213  0.019
All patients 12.3 18.6 14.8 22  18.8 30  0.493  0.117  0.117
p-values <0.05 are in bold type.
Table  2  Percentage  of  neutrophils  according  to  progression  of  time  and  initial  cell  number.
Initial  cell  number  Time  elapsed  after  ﬂuorescein  infusion  p-value
0  h  24  h  48  h  0  h  vs.  24  h  0  h  vs.  48  h  24  h  vs.  48  h
Mean  SD  Mean  SD  Mean  SD
≤5 13.2 29.9 41.7 35.9  24.2  26.6  0.118  0.459  0.108
≥6 23.5 25.9 37.1 32.6  22.5  25.5  0.259  0.901  0.267
All patients 18.1 27.8 39.5 33.6  23.4  25.4  0.048  0.530  0.050
p-values <0.05 are in bold type.
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tigure  3  Evolution  of  percentage  of  neutrophils  at  0  h,  24  h,
nd 48  h  in  relation  to  tests  that  showed  neutrophils  at  0  h  versus
hose who  did  not  present  any  neutrophils.
iscussion
ntrathecal  CSF  ﬂuorescein  staining  has  been  previously
escribed.6,7,12,15,16,19 This  procedure  allows  CSF  detection
rom  blood  or  secretions  present  in  the  operating  ﬁeld.  This
ustiﬁes  the  absence  of  a  control  group,  i.e.  without  appli-
ation  of  ﬂuorescein.
Intrathecal  application  of  ﬂuorescein  is  an  off-label  use
f  this  product  and  its  use  requires  documentation  and
 speciﬁc  discussion  with  the  patient,  requiring  informed
o
c
p
fritten  consent.8 Several  adverse  events  such  as  seizures,
ransient  paralysis,  and  neuropathic  pain  have  occasionally
een  attributed  to  its  use  in  literature.11,12,15 The  incidence
f  complications  remains  extremely  low  and  some  authors
eported  higher  percentages  in  patients  who  received  higher
r  more  concentrated  doses  than  that  described  in  this
tudy.15--19 The  pathophysiology  of  these  events  remains
nclear,  but  they  may  be  secondary  to  a  meningeal  inﬂam-
ation,  which  changes  the  chemistry  of  normal  CSF  and  its
ytology.8,12,15
Normal  CSF  has  a  protein  content  of  about  20--45  mg/dL.
he  glucose  level  in  this  medium  is  about  50--100  mg/dL;  CSF
ay  contain  up  to  ﬁve  cells  per  mL.  These  were  the  values
sed  in  this  study,  in  order  to  perform  this  evaluation.20
No  adverse  reactions  were  observed  with  the  use
f  an  intrathecal  hypodense  ﬂuorescein  solution  at  the
osage  described  in  this  study,  even  in  children.  With  this
osage,  the  skull  base  defect  visualization  was  considered
ffective.16,19
Nevertheless,  there  were  chemical  and  cytological
hanges  in  CSF.  In  36%  of  patients,  CSF  color,  which  was  clear
n  the  ﬁrst  collection,  changed  with  the  use  of  ﬂuorescein,
p  to  48  h  after  injection.  This  observation  can  be  corre-
ated  with  the  ﬁndings  of  cell  progression  and  percentage  of
eutrophils.
The  presence  of  ﬂuorescein  in  CSF  can  act  as  a  triggering
actor  for  neutrophilia  and  increased  cell  count,  as  well  as
o  their  subsequent  decrease  after  the  ﬂuorescein  levels  in
SF  diminished.
Although  a  lumbar  drainage  catheter  (used  only  for  CSF
ollection)  remained  in  all  patients,  it  cannot  be  assumed
hat  these  reactions  occurred  only  due  to  the  presence
f  this  device,  which  was  maintained  for  48  h.  In  that
ase,  the  catheter  would  increase  the  cell  count  in  all
atients,  in  a  direct  relation  to  the  exposure  time  --  a
act  that  was  not  observed.20 However,  the  possibility  that
ject
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phenylmercuric  nitrate  and  sodium  bicarbonate  may  cause
some  of  the  changes  observed  in  this  study  cannot  be  ruled
out.  Nonetheless,  the  cytological  changes  observed  were
minimal,  and  were  not  associated  with  side  effects.  Besides,
these  changes  can  be  even  smaller,  depending  on  the  pres-
ence  of  these  compounds  in  the  solution  used.
There  were  no  signiﬁcant  changes  in  glucose  levels  in  CSF.
This  ﬁnding  is  important,  since  none  of  the  patients  showed
any  symptom  of  bacterial  meningitis  during  the  study.  On  the
other  hand,  protein  levels  from  Group  1  patients  increased
at  the  24-h  and  48-h  (p  =  0.032)  measurements  vs.  Group  2
patients,  which  can  be  explained  by  the  increased  number
of  cells  present  in  the  CSF  samples  of  Group  1.
Conclusion
Based  on  these  results,  it  can  be  concluded  that  the
intrathecal  hypodense  ﬂuorescein  solution  (Fluidag®) pro-
motes  chemical  and  cytological  changes  in  CSF,  with  an
increase  in  cell  number  (mainly  at  24  h  and  48  h)  and  in  neu-
trophils  at  24  h  with  subsequent  decrease  at  48  h.  Protein
levels  increased  at  24  h  and  48  h.  There  were  no  changes  in
glucose  levels.  Nevertheless,  these  changes  did  not  translate
into  any  clinical  manifestations.
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